Economic Impact of a Vaccine Preventable Disease: A Scoping Review on Tuberculosis
Malaysian Journal of Medicine and Health Sciences
; : 254-261, 2020.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-829545
Responsible library:
WPRO
ABSTRACT
@#Using pulmonary tuberculosis (pTB) as an example of a vaccine-preventable disease (VPD), we aimed to gather evidence on the economic impact of treating a case or managing an outbreak of a VPD. A scoping review was conducted. Online databases (MEDLINE and Google Scholar) were used to collate published studies from the year 2015 to 2019 on the management cost of one case or an outbreak of pTB. Keywords used were cost, treatment, outbreak, pulmonary tuberculosis, tuberculosis, economic, economic evaluation. A total of 29 studies were analysed. The costs of pTB treatment for individual patient were higher in high-income countries compared to middle-income and low-income countries. A case of pTB can result in household catastrophic health expenditure; while an outbreak can overwhelm the health system’s capacity, and disrupts the economy of a country. Therefore, accessibility of vaccines especially in low-income countries must be ensured. Also, vaccine-hesitant individuals must reconsider their stance on vaccination.
Search on Google
Health context:
Sustainable Health Agenda for the Americas
/
Neglected Diseases
Health problem:
Goal 10: Communicable diseases
/
Goal 5: Medicines, vaccines and health technologies
/
Neglected Diseases
/
Tuberculosis
Database:
WPRIM (Western Pacific)
Type of study:
Health economic evaluation
/
Systematic review
Language:
English
Journal:
Malaysian Journal of Medicine and Health Sciences
Year:
2020
Document type:
Article